+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 68 Pages
  • September 2023
  • Region: Global
  • GlobalData
  • Charles River
  • ID: 1648587
Charles River Laboratories International Inc (CRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Charles River Laboratories International Inc (Charles River), is a contract research organization (CRO) that provides essential products and services to accelerate research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. The company also offers clinical, manufacturing and operations and staffing support. It provides solutions focused on therapy areas related to cardiovascular, central nervous system, metabolic, inflammation, oncology, ophthalmology, respiratory and musculoskeletal disorders. Charles River provides products and services to pharmaceutical and biotechnology companies, government agencies, besides leading hospitals and academic institutions. Charles River is headquartered in Wilmington, Massachusetts, the US.

Charles River Laboratories International Inc Key Recent Developments

  • Aug 01, 2023: Charles River Laboratories Expands Access to AAALAC-Accredited, Turnkey Research Space in Key Markets
  • Jun 13, 2023: Charles River Laboratories Launches Off-The-Shelf Lentiviral Vector Packaging Plasmids
  • Jun 12, 2023: Charles River and Curigin Collaborate to Produce Oncolytic Rnai Gene Therapy
  • Jun 08, 2023: Charles River and Inadcure Announce Gene Therapy Manufacturing Collaboration

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Charles River Laboratories International Inc - Key Facts
  • Charles River Laboratories International Inc - Key Employees
  • Charles River Laboratories International Inc - Key Employee Biographies
  • Charles River Laboratories International Inc - Major Products and Services
  • Charles River Laboratories International Inc - History
  • Charles River Laboratories International Inc - Company Statement
  • Charles River Laboratories International Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Charles River Laboratories International Inc - Business Description
  • Business Segment: Discovery and Safety Assessment
  • Overview
  • Performance
  • Business Segment: Manufacturing
  • Overview
  • Performance
  • Business Segment: Research Models and Services
  • Overview
  • Performance
  • Geographical Segment: Asia Pacific
  • Target Markets
  • Performance
  • Geographical Segment: Canada
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Other
  • Target Markets
  • Performance
  • Geographical Segment: US
  • Performance
  • Charles River Laboratories International Inc - Corporate Strategy
  • Charles River Laboratories International Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Charles River Laboratories International Inc - Strengths
  • Charles River Laboratories International Inc - Weaknesses
  • Charles River Laboratories International Inc - Opportunities
  • Charles River Laboratories International Inc - Threats
  • Charles River Laboratories International Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Charles River Laboratories International Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Aug 01, 2023: Charles River Laboratories Expands Access to AAALAC-Accredited, Turnkey Research Space in Key Markets
  • Jun 13, 2023: Charles River Laboratories Launches Off-The-Shelf Lentiviral Vector Packaging Plasmids
  • Jun 12, 2023: Charles River and Curigin Collaborate to Produce Oncolytic Rnai Gene Therapy
  • Jun 08, 2023: Charles River and Inadcure Announce Gene Therapy Manufacturing Collaboration
  • May 31, 2023: Wheeler Bio and Charles River Laboratories announce agreement to build and operate RightSource Laboratory
  • May 31, 2023: Charles River Laboratories and Wheeler Bio Announce Agreement to Build and Operate RightSource Laboratory
  • May 11, 2023: Charles River Laboratories Announces First-Quarter 2023 Results
  • May 01, 2023: Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID
  • Apr 10, 2023: Charles River Laboratories showcases end-to-end oncology capabilities at AACR 2023
  • Mar 14, 2023: Charles River launches Apollo, an industry-leading, secure, cloud-based platform for real-time toxicology study data
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Charles River Laboratories International Inc, Key Facts
  • Charles River Laboratories International Inc, Key Employees
  • Charles River Laboratories International Inc, Key Employee Biographies
  • Charles River Laboratories International Inc, Major Products and Services
  • Charles River Laboratories International Inc, History
  • Charles River Laboratories International Inc, Subsidiaries
  • Charles River Laboratories International Inc, Key Competitors
  • Charles River Laboratories International Inc, Ratios based on current share price
  • Charles River Laboratories International Inc, Annual Ratios
  • Charles River Laboratories International Inc, Interim Ratios
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Charles River Laboratories International Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Charles River Laboratories International Inc, Performance Chart (2018 - 2022)
  • Charles River Laboratories International Inc, Ratio Charts
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Charles River Laboratories International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Almac Group Ltd
  • The Jackson Laboratory
  • MLM Medical Labs GmbH
  • Pharmaceutical Product Development LLC
  • IMR Partner International Medical Research GmbH
  • Labcorp Drug Development
  • BioReliance Corp
  • Corgenix Medical Corp
  • The Jackson Laboratory
  • Redpoint Bio Corp
  • MLM Medical Labs GmbH
  • Pharmaceutical Product Development LLC
  • IMR Partner International Medical Research GmbH
  • Labcorp Drug Development
  • Almac Group Ltd
  • BioReliance Corp
  • Corgenix Medical Corp